P95 welcomes John O’Brien as Chief Business Officer
We are excited to welcome John O’Brien as our new Chief Business Officer! John has a proven track record of
We are excited to welcome John O’Brien as our new Chief Business Officer! John has a proven track record of
id.DRIVE is a Public-Private-Partnership, which consists of a unique consortium of pharmaceutical companies, public health institutes and research groups who
07/12/2023
In November, P95 took center stage at a pivotal event in Thailand’s clinical research scene—the National Clinical Research Network
Our P95 colleague Kaatje Bollaerts is excited to announce that the book ‘Vaccination Programmes | Epidemiology, Monitoring, Evaluation’ by Susan
October 16, 2023. Leuven, Belgium and Johannesburg, South Africa – P95 BV (“P95”), a portfolio company of Ampersand Capital Partners
Last week, P95 attended for the first time, the Congreso de Infectología 2023 organized by Asociación Panamericana de Infectología (API)